在异形性炎症性肌肉病的肺部表现的管理
Amita Krishnan1, Siddharth Jain2, Matthew R Lammi3
1Division of Pulmonary/Critical Care and Allergy/Immunology, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
Rheumatic diseases clinics of North America
|October 29, 2025
概括
异形性炎症性肌肉病 (IIM) 可以导致严重的肺部问题,主要是间歇性肺部疾病. 及时诊断和多学科护理对于管理这些肺部并发症至关重要.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 内部医学 内部医学
背景情况:
- 异形性炎症性肌肉病变 (IIM) 与显著的肺部发病率和死亡率有关.
- 间歇性肺病 (ILD) 是 IIM 患者中最常见的严重肺表现.
- 其他肺部并发症包括肺炎,肺中风,肺高血压,吸血,呼吸肌肉衰弱和肺癌风险.
研究的目的:
- 为了突出突出异常性炎症性肌肉病症中肺部并发症的频谱.
- 强调多学科方法在评估IIM患者呼吸短促时的重要性.
主要方法:
- 关于IIM肺部表现的综合文献综述.
- 讨论诊断工作,包括肺功能测试 (PFTs),CT扫描和心声回声.
- 强调了风湿病学和肺病学的合作作用.
主要成果:
- 间歇性肺病是主要的肺部并发症,需要免疫调节治疗.
- 可以出现各种各样的肺部问题,影响患者的治疗结果.
- 诊断评估需要一个彻底的,综合的方法.
结论:
- 肺部并发症显著导致IIM的发病率和死亡率.
- 早期识别和管理肺部症状至关重要.
- 多学科评估对于在IIM相关的肺部疾病中提供最佳的患者护理至关重要.
相关概念视频
Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
COPD: Management Using Bronchodilators and Corticosteroids
719
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
719
Myocarditis IV: Nursing Management
203
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
203
Cystic Fibrosis: Management
465
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
465
Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.0K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.0K


